A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a new study. Researchers were surprised at the finding because neither of the ...

At first glance, you might think that the study released last week comparing the cholesterol-lowering drugs Lipitor and Pravachol–funded by Pravachol’s maker–produced a surprise slam-dunk for Lipitor.

SAN FRANCISCO (CBS.MW) -- Bristol-Myers Squibb Co. said Friday after the bell that it intends to pursue approval from the U.S. Food and Drug Administration for an over-the-counter version of its ...

NEW ORLEANS -- Four and a half years ago, Bristol-Myers Squibb Co. placed a huge bet by announcing a 4,162-patient study pitting its cholesterol-lowering pill Pravachol against Pfizer Inc.'s Lipitor.

Cholesterol drug Lipitor, a top-selling medication from Pfizer, can halt, not just slow, the potentially fatal buildup of plaque in clogged arteries, researchers said Wednesday. Lipitor beat rival ...

Patients who are taking both aspirin and prescription Pravachol for cardiovascular problems may soon be able to buy new dual packs of the drugs approved by the Food and Drug Administration on ...